WEEKLY E-NEWS FROM THE NORTH CAROLINA BIOTECHNOLOGY CENTER

Join Us at CED's Biotech Forum

In partnership with the Biotechnology Center, CED will host its next Biotech Forum at the Biotechnology Center September 16 from 5:30 p.m.- 8 p.m. The event explores industry topics and trends, features expert speakers and provides high-quality networking opportunities for entrepreneurs, industry executives, students and investors.
 
For more information and to register visit www.cednc.org/btforum

FROM OUR WEB SITE

• Tryton Medical Gets Stent Patented
• Biotechnology Center Expanding
• FDA Approves InnerOptic Device
• BioMarck Raises $7.5M in New Financing
• Salix Drug Gets FDA Approval
• Oxygen Biotherapeutics Hits $6M Milestone
• Biotech Center Names Phillips Director of the Eastern Office
• Bayer, Precision Sign Seed Pact

DEPARTMENTS

• News from Other Sites
• Community Watch
• Events Calendar

From Our Web Site

Tryton Medical Gets Stent Patented
The Durham cardiac stent developer has been granted a patent on its lead product, the Side Branch Stent System.

Biotechnology Center Expanding
Partner support enabled the building project, designed to support North Carolina's fast-growing biotechnology industry.

FDA Approves InnerOptic Device
Hillsborough's InnerOptic got FDA approval to market its InVision 3D imaging system that enhances surgeons' maneuvering ability when they conduct laparoscopic procedures.

BioMarck Raises $7.5M in New Financing
RTP-based BioMarck has closed on another $7.5 million in private equity, according to Local Tech Wire.

Salix Drug Gets FDA Approval
Morrisville's Salix Pharmaceuticals got FDA marketing approval for its gastric distress drug, METOZOLV Orally Disintegrating Tablets.

Oxygen Biotherapeutics Hits $6M Milestone
Durham's Oxygen Biotherapeutics is selling another $6 million in stock to the Vatea Fund, thanks to its' go-ahead from Swiss regulators to start Phase II clinical trials of its lead prescription product, Oxycyte.

Biotech Center Names Phillips Director of the Eastern Office
Mark Phillips has joined the North Carolina Biotechnology Center as director of the Eastern Office, in Greenville.

Bayer, Precision Sign Seed Pact
Research Triangle Park-based Precision BioSciences has signed a collaborative agreement with Bayer CropScience to give Bayer non-exclusive access to some aspects of Precision's gene-modification technology for plants.

News from Other Sites

Biofuels: The Next Generation
A detailed overview of North Carolina's biofuels industry.
From the Stanly News and Press

FDA Approves Hillsborough Firm’s ‘GPS’ Device for Surgeons
Carolinas Medical Center has been working with InnerOptic on the device, which helps physicians to more quickly and accurately guide a needle into a target on an ultrasound image.
From Local Tech Wire

Medical Firm Seeks Incentives to Create 228 Jobs in Guilford County
The Baltimore-based company says it could also invest $26 million in property and equipment.
From the Greensboro News-Record

N.C. Biotech Center to Invest $10.4 Million in Headquarters Expansion
The addition will add 20,000 square feet of new office and conference space.
From Durham Herald Sun
From Local Tech Wire
From the (Raleigh) News & Observer
From Triangle Business Journal

Plant Design Emphasizes Green
United Therapeutics' new facility in Research Triangle Park meets LEED standards.
From FiercePharma Manufacturing

Community Watch

• Durham’s Inspire Pharmaceuticals has won the North Carolina Health & Life Sciences “Breakthrough Research” award at the Eastern North Carolina chapter of the National Multiple Sclerosis Society’s annual Dinner of Champions. More
  

• Pharmaceutical development veteran Frank Malinoski, M.D., Ph.D., president of Leland-based TD Consultancy, has become a volunteer consultant to Research Triangle Park nonprofit vaccine developer Global Vaccines. More
  

• Wilmington-based PPD has appointed Deborah Covington as global head of observational studies and pregnancy registries, leading the global contract research organization’s Phase IIIb-IV clinical trials, epidemiology, registries, observational studies and safety surveillance studies. More

Enter The Third Annual Graduate Student Poster Competition

The Charlotte Biotechnology Conference, scheduled for October 8, will feature its Third Annual Graduate Student Poster Competition. Any graduate student conducting biotechnology research with the potential for commercialization may apply by September 18. Four cash prizes will be awarded. For more eligibility requirements and to apply, visit www.charlotteresearchinstitute.com

Events Calendar

View our complete listing of events.

This newsletter was sent Thursday, September 10, 2009. For the latest headlines from North Carolina’s biotechnology industry, please visit our Web site news section.

Please respond to this e-mail if you cannot manage your subscription online.